EZZ Life Science Holdings Limited (ASX:EZZ)

EZZ Life Science Holdings Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 15, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	102	82	21	13	19	-
Market Cap Growth	421.73%	283.76%	61.08%	-29.08%	-	-
Enterprise Value	83	70	12	4	15	-
Last Close Price	2.17	1.81	0.48	0.28	0.41	-
PE Ratio	10.68	11.77	5.88	10.10	9.20	-
Forward PE	12.26	7.87	-	-	-	-
PS Ratio	1.36	1.23	0.57	0.88	0.84	-
PB Ratio	4.26	3.84	1.46	1.16	1.85	-
P/TBV Ratio	4.26	3.85	1.47	1.17	1.85	-
P/FCF Ratio	12.93	14.29	5.46	6.99	75.50	-
P/OCF Ratio	12.42	13.34	5.32	6.97	73.72	-
EV/Sales Ratio	1.11	1.05	0.32	0.29	0.67	-
EV/EBITDA Ratio	6.27	7.14	2.55	2.41	5.43	-
EV/EBIT Ratio	6.49	7.17	2.56	2.43	5.46	-
EV/FCF Ratio	10.48	12.14	3.02	2.29	60.63	-
Debt / Equity Ratio	0.02	0.01	0.03	0.01	0.01	0.01
Debt / EBITDA Ratio	0.04	0.01	0.10	0.05	0.03	0.01
Debt / FCF Ratio	0.06	0.02	0.12	0.06	0.32	0.01
Asset Turnover	3.00	3.08	2.33	1.14	2.45	3.95
Inventory Turnover	10.38	13.79	14.86	25.73	64.57	-
Quick Ratio	4.27	5.33	5.43	4.53	5.72	1.51
Current Ratio	5.37	5.96	5.80	4.96	6.08	1.61
Return on Equity (ROE)	45.86%	38.79%	27.95%	12.21%	32.44%	98.09%
Return on Assets (ROA)	31.95%	28.12%	18.08%	8.48%	18.85%	29.62%
Return on Capital (ROIC)	39.85%	33.27%	21.73%	10.29%	27.20%	82.52%
Return on Capital Employed (ROCE)	52.40%	45.50%	31.40%	15.60%	27.20%	89.50%
Earnings Yield	8.81%	8.50%	17.00%	9.90%	10.87%	-
FCF Yield	7.74%	7.00%	18.32%	14.30%	1.32%	-
Dividend Yield	1.84%	1.93%	4.16%	1.58%	1.11%	-
Payout Ratio	19.68%	15.53%	16.54%	13.20%	-	-
Buyback Yield / Dilution	-3.97%	-0.89%	-0.46%	-25.23%	-13.15%	-
Total Shareholder Return	-2.11%	1.05%	3.71%	-23.65%	-12.04%	-

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.